Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Nutriband Inc.

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Signs Partnership Agreement with Charlotte FC
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Issues Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Announces Seven-for-Six Forward Stock Split
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares
From Nutriband Inc.
Via AccessWire
Topics Lawsuit
Exposures Financial Legal
Tickers NTRB NTRBW
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
From Nutriband Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers NTRB NTRBW
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
From Nutriband Inc.
Via AccessWire
Tickers NTRB
Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice
From Nutriband Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers NTRB NTRBW
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office
From Nutriband Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers NTRB NTRBW
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers NTRB NTRBW
Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm
From Nutriband Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers NTRB NTRBW
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application
From Nutriband Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers NTRB NTRBW
Nutriband Inc. Announces $1 Million Share Repurchase Authorization
From Nutriband Inc.
Via AccessWire
Tickers NTRB NTRBW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.